← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2000Last known activity
Nov 23, 2021
Acquired by Meda Pharmaceuticals → Mylan on Jul 31, 2014
Timeline
1990s
- Jun 1, 1994
Rottapharm— Founded
2000s
- Jun 15, 2007
Madaus Inc— Acquired
2010s
- Jul 31, 2014
Meda Pharmaceuticals— Acquired By
- Feb 10, 2016
Mylan— Now
Drugs by trial phase (20 distinct, 24 trials)
Phase 3 (10 own, 4 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Cardiovascular Diseases
- Constipation
- Dementia
- Fatty Liver
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hypercholesterolemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypertriglyceridemia
- Irritable Bowel Syndrome
- Liver Diseases
- Lung Diseases
- Lung Diseases, Obstructive
- Metabolic Syndrome
- Non-alcoholic Fatty Liver Disease
- Osteoarthritis
- Osteoarthritis, Knee
- Parkinson Disease
- Pulmonary Disease, Chronic Obstructive
- Recurrence
- Syndrome
- Weight Loss
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (19)
- NCT05205330Lead sponsorPhase 1/Phase 2Nov 23, 2021
- NCT04788459CollaboratorPhase 1/Phase 2Feb 25, 2021
- NCT03163966Lead sponsorPhase 2Sep 1, 2017
- NCT01871662Lead sponsorPhase 2/Phase 3Aug 1, 2013
- NCT02295176Lead sponsorN/AApr 1, 2013
- NCT02006498CollaboratorPhase 2Jun 1, 2012
- NCT01562080Lead sponsorPhase 2/Phase 3Jan 1, 2012
- NCT01518933Lead sponsorPhase 2Aug 1, 2011
- NCT01535092Lead sponsorPhase 2Sep 1, 2010
- NCT01087632Lead sponsorN/ASep 1, 2009
- NCT00748787Lead sponsorPhase 2Oct 1, 2008
- NCT00503516Lead sponsorPhase 2/Phase 3Jun 1, 2007
- NCT00425074Lead sponsorPhase 1Jan 1, 2007
- NCT00507949Lead sponsorPhase 2Oct 1, 2006
- NCT00507715Lead sponsorPhase 1Sep 1, 2006
Details
- Founded
- Monza, IT Jun 1, 1994
- Last known activity
- Nov 23, 2021